Viewing Study NCT00309556

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:17 PM

Ignite Modification Date: 2026-03-29 @ 4:25 PM

Study NCT ID: NCT00309556

Status: COMPLETED

Last Update Posted: 2011-12-30

First Post: 2006-03-31

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Sponsor: Austrian Breast & Colorectal Cancer Study Group

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module